▲ Peaking
Health
Type 2 Diabetes: GLP-1 Mounjaro May Lower Heart Attack Risk
Recent reporting indicates the GLP-1 drug Mounjaro and related medications may lower heart attack risks for type 2 diabetes patients.
3 trends tracked about this subject — the full history, oldest to newest below.
Recent reporting indicates the GLP-1 drug Mounjaro and related medications may lower heart attack risks for type 2 diabetes patients.
Medical warnings are increasing as data reveals a surge of type 2 diabetes cases among young women, particularly those in their 20s.
Recent studies examine a low-protein longevity diet linked to healthier aging, fat reduction, and natural GLP-1 boosts in mice.